William Guyer

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

CORT

Current role

2 calls Latest call 2025-11-04

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Corcept Therapeutics Inc (CORT)	Pharm.D., Chief Development Officer	$706,387	$429,600	$17,871	$5,163,087	—	$23,500	$6,340,445
2024	Corcept Therapeutics Inc (CORT)	Pharm.D., Chief Development Officer	$656,210	$510,198	—	$2,804,219	—	$23,000	$3,993,627
2023	Corcept Therapeutics Inc (CORT)	Pharm.D., Chief Development Officer	$628,167	$379,800	$60,871	$2,764,760	—	$22,602	$3,856,200
2022	Corcept Therapeutics Inc (CORT)	Pharm.D., Chief Development Officer	$572,917	$345,000	$23,954	$1,107,285	—	$20,500	$2,069,656
2021	Corcept Therapeutics Inc (CORT)	Pharm.D. Chief Development Officer	$206,742	$247,500	—	$6,094,183	—	—	$6,548,425

Earnings-call appearances and filed executive appointments or departures, newest first.